Obstetrics/Gynecology
RSSArticles
-
LARC for the Medically Complicated Patient
Few medical conditions are absolute contraindications to long-acting reversible contraceptive methods.
-
Extending Life of LARCs: More Years for Your Implant
An international study found that continued use of an etonogestrel contraceptive implant for up to five years, two years longer than the current labeling approval, did not increase the risk of pregnancy.
-
When to Start Progestin-only Contraceptives After Medical Abortion
In this randomized, controlled trial, provision of depot medroxyprogesterone acetate on the same day as mifepristone for medical abortion decreased efficacy a small amount and had no effect on repeat pregnancy at six months. Whether this is clinically relevant will depend on individual patient counseling and the woman’s desire for convenient contraceptive coverage.
-
The Effect of Major Depression on Quality of Life After Surgery for Stress Urinary Incontinence
Women with major depression undergoing surgical treatment for stress urinary incontinence have worse condition-specific quality of life than non-depressed women. Postoperatively, depressed and non-depressed women have similar incontinence severity and quality of life.
-
The Best Medical Treatment for Endometriosis? The Debate Continues
In a “before and after study,” the proportion of satisfied and very satisfied women did not change from the “before” period, during which women with endometriosis were treated with norethindrone acetate, to the “after” period during treatment with dienogest.
-
Just Two HPV Shots Recommended for Younger Teens
The CDC now recommends that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart, rather than the previously recommended three doses.
-
Link Between Early Menopause, Higher Risk of Fracture Confirmed
A new analysis of data from the Women’s Health Initiative trial indicates an increased risk of fracture among women who reported early menopause (age 40 or younger), regardless of whether they were treated with hormone therapy and/or calcium and vitamin D supplementation.
-
Data Indicate Male Birth Control Shot May Be Effective
Men may be able to use birth control shots to prevent pregnancy in their female partners, data suggest in a just-published Phase II study.
-
Check Reproductive Health Considerations for Women Presenting with Rheumatoid Arthritis
Women diagnosed with rheumatoid arthritis must consider their drug treatment when choosing a contraceptive. Current treatment practice is to prescribe non-biologic disease-modifying antirheumatic drugs, which reduce disease activity and prevent joint deformity, within three months of diagnosis.
-
Data Support Five-year Use of Liletta
Data from a recent analysis of the 52 mg levonorgestrel Liletta intrauterine device indicate its calculated levonorgestrel content and release rate curves support the continued evaluation of its contraceptive use for five or more years.